The FDA again declined to approve Merck's proposed surgery drug, the latest in a string of research-and-development setbacks for the pharmaceutical maker.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304213904579093030516236934.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304213904579093030516236934.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento